NCT01719172

A Prospective, Multi-Center, Single-Arm Study of the Veriset™ Hemostatic Patch in Controlling Bleeding in Soft Tissue

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 30 (actual)
• Sponsor: Medtronic - MITG · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The objective of this study is to determine the safety of Veriset™ Hemostatic Patch when used during non-emergent, open, soft tissue surgery where a topical hemostatic agent would be used.

Conditions

• Non-emergent, Soft Tissue Procedures, Performed Via an Open Approach

Interventions

Type	Name	Description
DEVICE	Veriset™ Hemostatic Patch	Topical Hemostat

Timeline

• Start date: 2012-09-01
• Primary completion: 2013-05-01
• Completion: 2013-06-01
• First posted: 2012-11-01
• Last updated: 2014-02-27
• Results posted: 2014-02-27

Locations

3 sites across 2 countries: Austria, Germany